Sign in
BTTX Stock Price, Chart, Stats & News
Better Therapeutics, Inc.
Save
Better Therapeutics, Inc. (BTTX) does not currently pay a dividend.
5,452
Market cap
–
Current P/E
–
Forward P/E
BTTX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -0.02% |
ROA | -173.30% |
ROE | -221.99% |
D/E | -16.55x |
Interest coverage ratio | -25.66x |
BTTX valuation
P/E | – |
P/S | – |
P/B | -0.00x |
P/CF | -0.00x |
P/FCF | -0.00x |
P/OCF | -0.00x |
PEG | -0.00x |
EV multiple | -0.02x |
About
Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company’s lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions.
Similar securities
Based on sector and market capitalization
Report issue